A Randomized Phase 3 Study of Sitravatinib in
Combination with Nivolumab Versus Docetaxel in
Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy

IRB/UVA Tracking #
21856
Contact
Maria Davenport
Contact Email
Contact Phone
1.434.297.4110
Phase
III
Primary purpose
Treatment
Cancer PI
Richard Hall
Status
OPEN TO ACCRUAL
Ages
Adult